|
1
|
Combined postmenopausal hormone therapy and cardiovascular disease: toward resolving the discrepancy between observational studies and the Women's Health Initiative clinical trial.
|
Am J Epidemiol
|
2005
|
4.55
|
|
2
|
Effects of estrogen plus progestin on risk of fracture and bone mineral density: the Women's Health Initiative randomized trial.
|
JAMA
|
2003
|
4.07
|
|
3
|
Conjugated equine estrogens and coronary heart disease: the Women's Health Initiative.
|
Arch Intern Med
|
2006
|
3.91
|
|
4
|
Calcium plus vitamin D supplementation and the risk of breast cancer.
|
J Natl Cancer Inst
|
2008
|
3.60
|
|
5
|
Benefits and risks of postmenopausal hormone therapy when it is initiated soon after menopause.
|
Am J Epidemiol
|
2009
|
3.33
|
|
6
|
Conjugated equine estrogens and breast cancer risk in the Women's Health Initiative clinical trial and observational study.
|
Am J Epidemiol
|
2008
|
3.05
|
|
7
|
Effects of estrogen plus progestin on gynecologic cancers and associated diagnostic procedures: the Women's Health Initiative randomized trial.
|
JAMA
|
2003
|
2.90
|
|
8
|
Assessment of clinical validity of a breast cancer risk model combining genetic and clinical information.
|
J Natl Cancer Inst
|
2010
|
2.82
|
|
9
|
Estrogen plus progestin therapy and breast cancer in recently postmenopausal women.
|
Am J Epidemiol
|
2008
|
2.79
|
|
10
|
Frequency and predictive value of a mammographic recommendation for short-interval follow-up.
|
J Natl Cancer Inst
|
2003
|
2.64
|
|
11
|
Large-scale gene-centric meta-analysis across 39 studies identifies type 2 diabetes loci.
|
Am J Hum Genet
|
2012
|
2.53
|
|
12
|
Low-fat dietary pattern and cancer incidence in the Women's Health Initiative Dietary Modification Randomized Controlled Trial.
|
J Natl Cancer Inst
|
2007
|
2.37
|
|
13
|
Estrogen plus progestin and breast cancer detection by means of mammography and breast biopsy.
|
Arch Intern Med
|
2008
|
1.94
|
|
14
|
Economic return from the Women's Health Initiative estrogen plus progestin clinical trial: a modeling study.
|
Ann Intern Med
|
2014
|
1.87
|
|
15
|
Fracture risk among breast cancer survivors: results from the Women's Health Initiative Observational Study.
|
Arch Intern Med
|
2005
|
1.85
|
|
16
|
Statin use, clinical fracture, and bone density in postmenopausal women: results from the Women's Health Initiative Observational Study.
|
Ann Intern Med
|
2003
|
1.81
|
|
17
|
Effects of postmenopausal hormone therapy on rheumatoid arthritis: the women's health initiative randomized controlled trials.
|
Arthritis Rheum
|
2008
|
1.80
|
|
18
|
Low-fat dietary pattern and lipoprotein risk factors: the Women's Health Initiative Dietary Modification Trial.
|
Am J Clin Nutr
|
2010
|
1.73
|
|
19
|
Statistical issues arising in the Women's Health Initiative.
|
Biometrics
|
2005
|
1.72
|
|
20
|
Predictors of serum 25-hydroxyvitamin D concentrations among postmenopausal women: the Women's Health Initiative Calcium plus Vitamin D clinical trial.
|
Am J Clin Nutr
|
2010
|
1.67
|
|
21
|
Insecticide use and risk of rheumatoid arthritis and systemic lupus erythematosus in the Women's Health Initiative Observational Study.
|
Arthritis Care Res (Hoboken)
|
2011
|
1.64
|
|
22
|
The influence of health and lifestyle characteristics on the relation of serum 25-hydroxyvitamin D with risk of colorectal and breast cancer in postmenopausal women.
|
Am J Epidemiol
|
2012
|
1.62
|
|
23
|
Combined analysis of Women's Health Initiative observational and clinical trial data on postmenopausal hormone treatment and cardiovascular disease.
|
Am J Epidemiol
|
2006
|
1.54
|
|
24
|
Variation in the FGFR2 gene and the effects of postmenopausal hormone therapy on invasive breast cancer.
|
Cancer Epidemiol Biomarkers Prev
|
2009
|
1.46
|
|
25
|
Effects of conjugated equine estrogen on risk of fractures and BMD in postmenopausal women with hysterectomy: results from the women's health initiative randomized trial.
|
J Bone Miner Res
|
2006
|
1.45
|
|
26
|
Estrogen alone and joint symptoms in the Women's Health Initiative randomized trial.
|
Menopause
|
2013
|
1.42
|
|
27
|
Inflammatory, lipid, thrombotic, and genetic markers of coronary heart disease risk in the women's health initiative trials of hormone therapy.
|
Arch Intern Med
|
2008
|
1.34
|
|
28
|
Monitoring and reporting of the Women's Health Initiative randomized hormone therapy trials.
|
Clin Trials
|
2007
|
1.33
|
|
29
|
Colorectal cancer in relation to postmenopausal estrogen and estrogen plus progestin in the Women's Health Initiative clinical trial and observational study.
|
Cancer Epidemiol Biomarkers Prev
|
2009
|
1.29
|
|
30
|
Loci influencing blood pressure identified using a cardiovascular gene-centric array.
|
Hum Mol Genet
|
2013
|
1.27
|
|
31
|
Osteoporosis and rate of bone loss among postmenopausal survivors of breast cancer.
|
Cancer
|
2005
|
1.23
|
|
32
|
Vigorous leisure activity through women's adult life: the Women's Health Initiative Observational Cohort Study.
|
Am J Epidemiol
|
2002
|
1.17
|
|
33
|
Lack of a relation between vitamin and mineral antioxidants and bone mineral density: results from the Women's Health Initiative.
|
Am J Clin Nutr
|
2005
|
1.14
|
|
34
|
Incident invasive breast cancer, geographic location of residence, and reported average time spent outside.
|
Cancer Epidemiol Biomarkers Prev
|
2009
|
1.11
|
|
35
|
Estrogen alone in postmenopausal women and breast cancer detection by means of mammography and breast biopsy.
|
J Clin Oncol
|
2010
|
1.03
|
|
36
|
Regression calibration in nutritional epidemiology: example of fat density and total energy in relationship to postmenopausal breast cancer.
|
Am J Epidemiol
|
2013
|
0.90
|
|
37
|
Effects of a low-fat dietary intervention on glucose, insulin, and insulin resistance in the Women's Health Initiative (WHI) Dietary Modification trial.
|
Am J Clin Nutr
|
2011
|
0.90
|
|
38
|
Prospective analysis of association between use of statins and melanoma risk in the Women's Health Initiative.
|
Cancer
|
2012
|
0.87
|
|
39
|
Caution in reinterpreting the Women's Health Initiative (WHI) Calcium and Vitamin D Trial breast cancer results.
|
Am J Clin Nutr
|
2012
|
0.87
|
|
40
|
Insulin, physical activity, and caloric intake in postmenopausal women: breast cancer implications.
|
J Clin Oncol
|
2004
|
0.87
|
|
41
|
Demographic and health factors associated with enrollment in posttrial studies: the Women's Health Initiative Hormone Therapy Trials.
|
Clin Trials
|
2013
|
0.86
|
|
42
|
Incidence of cervical cytological abnormalities with aging in the women's health initiative: a randomized controlled trial.
|
Obstet Gynecol
|
2006
|
0.85
|
|
43
|
Tissue factor pathway inhibitor, activated protein C resistance, and risk of ischemic stroke due to postmenopausal hormone therapy.
|
Stroke
|
2012
|
0.83
|
|
44
|
25-hydroxyvitamin D concentration, vitamin D intake and joint symptoms in postmenopausal women.
|
Maturitas
|
2010
|
0.82
|
|
45
|
An exploratory study of respiratory quotient calibration and association with postmenopausal breast cancer.
|
Cancer Epidemiol Biomarkers Prev
|
2013
|
0.80
|
|
46
|
Calcium and vitamin D supplementation and incident rheumatoid arthritis: the Women's Health Initiative Calcium plus Vitamin D trial.
|
Rheumatol Int
|
2011
|
0.80
|
|
47
|
Impact of cyclooxygenase inhibitors in the Women's Health Initiative hormone trials: secondary analysis of a randomized trial.
|
PLoS Clin Trials
|
2006
|
0.79
|
|
48
|
Calcium plus vitamin D supplementation and joint symptoms in postmenopausal women in the women's health initiative randomized trial.
|
J Acad Nutr Diet
|
2013
|
0.78
|
|
49
|
Calcium and heart attacks. No evidence for increased risk.
|
BMJ
|
2010
|
0.78
|
|
50
|
Another treatment gap: restarting secondary prevention medications: the Women's Health Initiative.
|
J Clin Lipidol
|
2010
|
0.75
|
|
51
|
Laxative use and incident falls, fractures and change in bone mineral density in postmenopausal women: results from the Women's Health Initiative.
|
BMC Geriatr
|
2013
|
0.75
|
|
52
|
Re: Short-interval follow-up mammography: are we doing the right thing?
|
J Natl Cancer Inst
|
2003
|
0.75
|